GH
SCLN

GAM Holding’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

GAM Holding’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-541,025
Closed -$6.06M – 919
2017
Q3 		$6.06M Buy
541,025
+153,649
+40% +$1.69M 0.26% 122
2017
Q2 		$4.26M Buy
+387,376
New +$3.87M 0.06% 364

GAM Holding's SCLN Position: Q4 2017 in Review

GAM Holding sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 541,025 shares — an estimated $6.06M sold.

GAM Holding first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $6.06M in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • GAM Holding reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • GAM Holding sold 541,025 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $6.06M.
  • GAM Holding first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • GAM Holding's Sciclone Pharmaceuticals Inc position peaked at $6.06M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on GAM Holding's 13F filing for Q4 2017, filed 14 Feb 2018.